Peter Evan Harwin
CIK 1663607 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$257.83M
Companies
10
Total Filings
23
Lifetime Open-Market Net
$27.41M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Director | — | $33.10 | — | $0 | 6 | 2026-06-11 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | — | $15.70 | — | $0 | 2 | 2026-06-03 |
| ZBIO | Director | 2,209,025 | $19.80 | $43.74M | $24.03M | 2 | 2025-10-09 |
| JBIO | Director | — | $15.34 | — | $0 | 1 | 2025-05-01 |
| ORKA | Director | 798,614 | $69.89 | $55.82M | $0 | 1 | 2024-11-21 |
| VRDN | Director | — | $16.35 | — | $0 | 5 | 2024-06-28 |
| APGE | Director | — | $88.33 | — | $0 | 1 | 2024-06-07 |
| DNTH | Director | 1,928,503 | $82.07 | $158.27M | $3.38M | 3 | 2023-10-03 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 1 | 2020-10-29 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 1 | 2020-08-31 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-08 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2020-10-29 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-31 | Cogent Biosciences, Inc. (UMRX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.